Friday 6 November 2026
Export CDNA’s income statement to Excel — free account
CareDx, Inc.
CDNA Healthcare Diagnostics & Research
CareDx, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $379.8 million, up 13.8% from fiscal 2024.
- Revenue
- +39.3%
- EPS
- +1,133.3%
- Free cash flow
- −68.6%
Quarter to September 2026, against a year earlier
77.99
1.66
+2.17%
Follow CDNA
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| 33.04% | 29.49% | (2.36%) | (6.27%) |
+8 more TTM periods Free account |
|
Piotroski F-Score |
7 | 8 | 6 | 5 | |
| 23.96% | 22.72% | (1.82%) | (4.72%) | ||
ROIC |
33.56% | 130.06% | (8.02%) | (15.28%) | |
Return on Tangible Assets |
61.45% | 30.64% | (3.67%) | (10.66%) | |
Average Days of Receivables |
35.03 | 27.39 | 39.42 | 40.97 | |
Free Cash Flow per Share |
1.15 | 1.65 | 1.27 | 0.65 | |
Free Cash Flow |
59.76 | 84.71 | 64.85 | 34.55 | |
Capital Expenditures |
(9.26) | (8.95) | (8.10) | (7.48) | |
| Other line items | |||||
Cash ROIC |
8.32% | 10.60% | 12.95% | 7.19% | |
Accounts Receivable Turnover |
10.41 | 9.01 | 7.11 | 7.08 | |
Accounts Payable Turnover |
12.89 | 13.92 | 14.99 | 13.95 | |
Inventory Turnover |
7.71 | 7.72 | 5.21 | 5.33 | |
Average Days of Payables |
27.32 | 25.71 | 25.76 | 29.58 | |
Days of Inventory on Hand |
23.11 | 18.91 | 75.03 | 79.09 | |
Tax Rate |
0.04 | (0.04) | 0.02 | 0.01 | |
Research and Development Expense of Revenue |
16.97% | 17.43% | 18.00% | 18.81% | |
Selling, General and Administrative Expense of Revenue |
53.17% | 54.07% | 54.58% | 55.35% | |
Share Based Compensation of Revenue |
7.68% | 8.07% | 8.66% | 9.18% | |
Operating CF/Net income |
0.54 | 0.84 | (8.90) | (1.97) | |
Depreciation/Fixed assets |
0.92 | 0.82 | 0.67 | 0.66 | |
Capex/Depreciation |
(0.37) | (0.41) | (0.37) | (0.35) | |
Revenue per Share |
9.54 | 8.90 | 8.07 | 7.13 | |
Operating CF per Share |
1.32 | 1.82 | 1.43 | 0.79 | |
Capex per Share |
(0.18) | (0.17) | (0.16) | (0.14) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 5 Nov 2026